Our Portfolio

An overview of our current and past investments

Araris

Araris is pioneering the development of a novel antibody-drug conjugate (ADC)-linker technology that enables payload attachment to ‘off-the-shelf’ antibodies in one step.

Eyenovia

Eyenovia is a clinical stage company transforming the delivery of therapeutics for the treatment of prominent eye diseases.

Hillo

Hillo supports diabetic patients in treatment decision making with an AI tool for personal glycemia level prediction.

ImmunOs

ImmunOs is leading in the discovery and development of the next generation of novel human immunomodulatory proteins for cancer treatment.

Kamari Pharma

Kamari Pharma is a clinical-stage biopharmaceutical company developing small molecule inhibitors of TRPV3 for the treatment of dermatological conditions with unmet need.

NETRIS Pharma

NETRIS Pharma is a clinical stage immuneoncology company targeting the biology of dependence receptors.

Newronika

Newronika builds innovative brain devices adapting patient's therapy following real time changes in deep neuronal networks.

Oculis

Oculis is a clinical-stage biopharmaceutical company developing novel topical treatments for ophthalmic diseases for back & front of the eye.

Raziel Therapeutics

Raziel Therapeutics is developing a proprietary new drug for aesthetic applications, and fat disorders with a single injection treatment into subcutaneous fat.

Redbiotec

Redbiotec develops immunotherapies against Herpes and Cancer based on best-in-class proteins and microorganisms.

SamanTree

SamanTree has developed a confocal microscopy scanner for high-resolution imaging of fresh tissue for oncological applications.

Spiral Therapeutics

Spiral is a clinical stage company focused on the development of first-in-class therapies to target hearing loss and other inner ear disorders.

T3 Pharma

T3 is a pre-clinical company working to advance new generation therapies for cancer patients using live bacteria.

Tolremo

Tolremo engages in the discovery and development of molecule drugs targeting drug resistance in cancer therapy.

Visus

Visus is a clinical-stage pharmaceutical company developing presbyopia-correcting eye-drop.

View More You’ve reached the end of the list

All

Buyout

ICT

Life Sciences

Araris is pioneering the development of a novel antibody-drug conjugate (ADC)-linker technology that enables payload attachment to ‘off-the-shelf’ antibodies in...

Eyenovia is a clinical stage company transforming the delivery of therapeutics for the treatment of prominent eye diseases.

Hillo supports diabetic patients in treatment decision making with an AI tool for personal glycemia level prediction.

ImmunOs is leading in the discovery and development of the next generation of novel human immunomodulatory proteins for cancer treatment.

Kamari Pharma is a clinical-stage biopharmaceutical company developing small molecule inhibitors of TRPV3 for the treatment of dermatological conditions with...

NETRIS Pharma is a clinical stage immuneoncology company targeting the biology of dependence receptors.

Newronika builds innovative brain devices adapting patient's therapy following real time changes in deep neuronal networks.

Oculis is a clinical-stage biopharmaceutical company developing novel topical treatments for ophthalmic diseases for back & front of the eye.

Raziel Therapeutics is developing a proprietary new drug for aesthetic applications, and fat disorders with a single injection treatment into...

Redbiotec develops immunotherapies against Herpes and Cancer based on best-in-class proteins and microorganisms.

SamanTree has developed a confocal microscopy scanner for high-resolution imaging of fresh tissue for oncological applications.

Spiral is a clinical stage company focused on the development of first-in-class therapies to target hearing loss and other inner...

View More You’ve reached the end of the list

Our Approach

Our Focus

Venture Capital & Buyout

Stage

Geography

Industry

Ticket

OUR PHILOSOPHY

Long-Term

Loyal Partner

Entrepreneurial Spirit